Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 441951
Gene Symbol: ZFAS1
ZFAS1
0.040 Biomarker disease BEFREE The study demonstrated that lncRNA ZFAS1 may act as a promoter of tumorigenesis and metastasis in nasopharyngeal carcinoma, by up-regulating the expression of LPAR1 in a miR-892b-dependent manner. 31851778 2020
Entrez Id: 1902
Gene Symbol: LPAR1
LPAR1
0.010 AlteredExpression disease BEFREE Long noncoding RNA ZFAS1 promotes tumorigenesis and metastasis in nasopharyngeal carcinoma by sponging miR-892b to up-regulate LPAR1 expression. 31851778 2020
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.400 AlteredExpression disease BEFREE After exposure to PSH on NPC, the expression of MMP-2 is downregulated and EMT is suppressed through MAPK signaling pathways. 31850235 2019
Entrez Id: 7431
Gene Symbol: VIM
VIM
0.100 Biomarker disease BEFREE Additionally, PSH upregulated the expression levels of E-cadherin and Claudin-1 while downregulating that of N-cadherin and vimentin on both NPC cell lines. 31850235 2019
Entrez Id: 1366
Gene Symbol: CLDN7
CLDN7
0.030 Biomarker disease BEFREE Additionally, PSH upregulated the expression levels of E-cadherin and Claudin-1 while downregulating that of N-cadherin and vimentin on both NPC cell lines. 31850235 2019
Entrez Id: 9076
Gene Symbol: CLDN1
CLDN1
0.030 Biomarker disease BEFREE Additionally, PSH upregulated the expression levels of E-cadherin and Claudin-1 while downregulating that of N-cadherin and vimentin on both NPC cell lines. 31850235 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100 AlteredExpression disease BEFREE Programmed death ligand 1 (PD-L1) expression on NPC correlates with clinical outcomes. 31850219 2019
Entrez Id: 5037
Gene Symbol: PEBP1
PEBP1
0.040 Biomarker disease BEFREE Targeting miR-181a/RKIP axis may be a valid path for reinforcing radiosensitivity and eventually improving the outcomes of clinical treatment in NPC. 31849491 2019
Entrez Id: 10577
Gene Symbol: NPC2
NPC2
0.100 Biomarker disease BEFREE In this review, we will mainly summarize the molecular characteristics and biological significance of NPC2, highlighting its vital roles in NPC disease. 31843136 2020
Entrez Id: 414777
Gene Symbol: HCG18
HCG18
0.010 AlteredExpression disease BEFREE We found that HCG18 expression was upregulated in both NPC specimens and cell lines. 31841193 2019
Entrez Id: 545
Gene Symbol: ATR
ATR
0.030 AlteredExpression disease BEFREE We compared the expression levels of ATR kinases in human nasopharyngeal carcinoma, choriocarcinoma and chondrosarcoma cell lines. 31839711 2019
Entrez Id: 117178
Gene Symbol: SSX2IP
SSX2IP
0.010 AlteredExpression disease BEFREE We associated high levels of SSX2IP immunoexpression with aggressive pathological features and worse oncological outcomes, suggesting its potential therapeutic value for patients with NPC. 31837171 2019
Entrez Id: 9260
Gene Symbol: PDLIM7
PDLIM7
0.100 Biomarker disease BEFREE LMP1 DNA and EBER1 RNA correlated with the metastasis of nasopharyngeal carcinoma. 31832991 2019
Entrez Id: 10859
Gene Symbol: LILRB1
LILRB1
0.020 AlteredExpression disease BEFREE The interregulation and correlation among CCAT1, miR7-5p and SP1, and the feedback regulatory loop unveil the novel molecular mechanism underlying the overall responses of SM in anti-NPC. 31823440 2020
Entrez Id: 100507056
Gene Symbol: CCAT1
CCAT1
0.020 AlteredExpression disease BEFREE The regulation and interaction of colon cancer-associated transcript-1 and miR7-5p contribute to the inhibition of SP1 expression by solamargine in human nasopharyngeal carcinoma cells. 31823440 2020
Entrez Id: 4072
Gene Symbol: EPCAM
EPCAM
0.030 Biomarker disease BEFREE In this study, the prognostic impact of histopathologic features including EpCAM for nasopharyngeal cancer (NPC) patients was investigated. 31822892 2020
Entrez Id: 2875
Gene Symbol: GPT
GPT
0.010 Biomarker disease BEFREE Pretreatment Aspartate Aminotransferase-to-Alanine Aminotransferase (De Ritis) Ratio Predicts the Prognosis of Nonmetastatic Nasopharyngeal Carcinoma. 31819502 2019
Entrez Id: 9891
Gene Symbol: NUAK1
NUAK1
0.040 Biomarker disease BEFREE The LINC00958-miR-625-NUAK1 pathway might be a target for anticancer therapy in patients with NPC. 31819474 2019
Entrez Id: 100506305
Gene Symbol: LINC00958
LINC00958
0.010 AlteredExpression disease BEFREE Downregulation of LINC00958 suppressed NPC cell proliferation, migration, and invasion and induced apoptosis in vitro. 31819474 2019
Entrez Id: 693210
Gene Symbol: MIR625
MIR625
0.010 Biomarker disease BEFREE The LINC00958-miR-625-NUAK1 pathway might be a target for anticancer therapy in patients with NPC. 31819474 2019
Entrez Id: 56898
Gene Symbol: BDH2
BDH2
0.010 AlteredExpression disease BEFREE Ectopic expression of BDH2 inhibited NPC cell proliferation and colony formation. 31819181 2020
Entrez Id: 885
Gene Symbol: CCK
CCK
0.040 Biomarker disease BEFREE Cell viability were determined by Cell counting kit-8 (CCK-8) and was further performed to explore the NPC cell sensitivity for paclitaxel. 31813603 2020
Entrez Id: 406940
Gene Symbol: MIR148A
MIR148A
0.030 AlteredExpression disease BEFREE XIST was upregulated and miR-148a-3p was downregulated in NPC tissues and cell lines. 31810117 2020
Entrez Id: 6868
Gene Symbol: ADAM17
ADAM17
0.020 Biomarker disease BEFREE LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. 31810117 2020
Entrez Id: 108353832
Gene Symbol: CNE-2
CNE-2
0.100 Biomarker disease BEFREE This study examined four human cancer cell lines including A549 (lung adenocarcinoma), U251MG (glioma), Tca8113 (tongue squamous carcinoma), and CNE-2 (nasopharyngeal carcinoma). 31807524 2019